Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer (Q43780694)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2001
edit
Language Label Description Also known as
English
Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer
scientific article published in June 2001

    Statements

    Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer (English)
    M Baekelandt
    I Szántó
    P Pfeiffer
    B Gustavssson
    G B Kristensen
    1 June 2001
    2983-2993

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit